Immuron Successfully Completes NASH Phase II Clinical Study Milestone MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercialising oral...

Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing NEW YORK, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT), a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is...

ISR Projects Continued Growth Propelling the CRO Market Forward CARY, NC--(Marketwired - February 02, 2016) -  Industry Standard Research (ISR) today announced a new addition to its Market Analysis suite of reports. The "2016 Edition of the CRO Market Size...

Accenture, ICON Among Providers Shortlisted in ISR's 7th Annual CRO Quality Benchmarking Study CARY, NC--(Marketwired - May 06, 2015) - Industry Standard Research (ISR) has announced the availability of its 7th annual CRO Quality Benchmarking series with the release of its "CRO Quality...